SAUSALITO, Calif.--(BUSINESS WIRE)--Canna Angels LLC, a dedicated angel investment consortium at the forefront of investment opportunities in the cannabis industry, announces their three year anniversary, boasting an outstanding alumni portfolio of 52 carefully curated companies as rising stars within the cannabis industry.
In less than three years, Canna Angels’ portfolio of companies has achieved five exits; four by acquisition and one by RTO on the Canadian exchange (CSE). Exits include the recent acquisition of Zephr by New Frontier Data and Lodestone Technologies by Yobi, another Canna Angels alum. The portfolio of 52 companies collectively have shown impressive progress and are considered industry leaders. Many are progressing through expansive growth and secondary raises.
Canna Angels CEO, Sherri Haskell attributes much of this success to the company’s focus on funding infrastructure and highly scalable technologies positioned as critical to industry success. Ms. Haskell shares, “The Canna Angels strategy, and dominant focus on technology innovators has positioned us as a draw for many of the brightest emerging leaders in the cannabis industry.” Haskell opines that the technologies building and sustaining the cannabis industry will be the foundation for broader global expansions.
Canna Angels is also pleased to announce the appointment of CEO Sherri Haskell to the Advisory Board of Cannabidose Medical, an exciting, visionary, Israeli company. Cannabidose, at the forefront of cannabinoid dosing solutions has accrued international patents and major contracts, including a partnership with Merck Group of Germany. Their award-winning design technology for innovative, precise, consumer delivery systems is garnering attention globally.
ABOUT CANNA ANGELS, LLC.
Canna Angels, a dedicated Angel-to-A investment consortium, is a proven leader at identifying and attracting exceptional investment opportunities in the cannabis industry. Our sole purpose is to provide our accredited investors with carefully vetted, high quality, emerging companies; those scalable and foundational to the industry.
Our discriminating investment thesis leads the opportunity curve, providing early access to potentially lucrative investments. The Canna Angels skillful team searches for, and diligently selects the most outstanding rising stars in the cannabis industry, to present to our Investor Members. Current investors include accredited, family office, wealth managers, funds, and boutique institutions.
Canna Angels’ goal is to maximize the potential for both entrepreneurs and investors to succeed as partners in the complex and dynamic opportunities offered in the cannabis industry.